Patient with HAE and normal C1-INH treated with Takhzyro

Treatment with Takhzyro (lanadelumab) led to a more than 80% reduction in swelling attacks in a woman with hereditary angioedema (HAE) and normal C1-inhibitor (C1-INH) activity, a case study reports. The medication effectively reduced both the frequency and severity of the attacks, leading to ongoing benefits for this…

Having an Excellent Reason to Raise Your Voice

“Nope!” I said matter-of-factly to my general practitioner. “The only thing that does is make me feel loopy.” “We can’t have that,” he replied. He jotted something down on his trusty prescription pad, ripped off the top sheet, and handed it to me. “Let me know if this works for…

Not Majoring in Minor Health Moments

The familiar number flashed across my phone screen, and I audibly groaned. After a particularly arduous morning dealing with late school buses, forgotten lunches, and a few involved errands, I had finally reached a moment where everything settled. Yet the sound of my phone vibrating against the table yanked me…